Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broncho-Vaxom in seasonal allergic rhinitis
ISRCTN37877803Phase 2Completed
- Sponsor
- OM Pharma
- Start
- Aug 2007
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in seasonal allergic rhinitis (SAR) comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoint: Combined clinical threshold to allergen nasal provocation test. Started Aug 2007; status: completed.
02
Drugs
OM-85
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ISRCTN37877803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37877803.